Nintedanib for progressive fibrosing interstitial lung disease: how many meet criteria in a UK district general hospital systemic sclerosis cohort?
Ho GN Douglas KMJ
Ho GN
Douglas KMJ
Citations
Altmetric:
Affiliation
The Dudley Group NHS Foundation Trust
Other Contributors
Publication date
03/04/2023
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Citation
Ho GN, Douglas KMJ. Nintedanib for progressive fibrosing interstitial lung disease: how many meet criteria in a UK district general hospital systemic sclerosis cohort? Rheumatol Adv Pract. 2023 Apr 3;7(2):rkad037. doi: 10.1093/rap/rkad037. PMID: 37065010; PMCID: PMC10097451.
Type
Article